192 related articles for article (PubMed ID: 34290294)
1. The expression of FLNA and CLU in PBMCs as a novel screening marker for hepatocellular carcinoma.
Patarat R; Riku S; Kunadirek P; Chuaypen N; Tangkijvanich P; Mutirangura A; Puttipanyalears C
Sci Rep; 2021 Jul; 11(1):14838. PubMed ID: 34290294
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic value of clusterin immunostaining in hepatocellular carcinoma.
Li Y; Liu F; Zhou W; Zhang S; Chu P; Lin F; Wang HL
Diagn Pathol; 2020 Oct; 15(1):127. PubMed ID: 33054843
[TBL] [Abstract][Full Text] [Related]
3. Clusterin role in hepatocellular carcinoma patients treated with oxaliplatin.
Wang X; Liu Y; Qin Q; Zheng T
Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32039450
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic performance of clusterin in hepatocellular carcinoma: A meta-analysis.
Gao G; Luan X
Int J Biol Markers; 2022 Dec; 37(4):404-411. PubMed ID: 35645149
[TBL] [Abstract][Full Text] [Related]
5. Clusterin facilitates metastasis by EIF3I/Akt/MMP13 signaling in hepatocellular carcinoma.
Wang C; Jin G; Jin H; Wang N; Luo Q; Zhang Y; Gao D; Jiang K; Gu D; Shen Q; Huo X; Hu F; Ge T; Zhao F; Chu W; Shu H; Yao M; Cong W; Qin W
Oncotarget; 2015 Feb; 6(5):2903-16. PubMed ID: 25609201
[TBL] [Abstract][Full Text] [Related]
6. Clusterin contributes to hepatitis C virus-related hepatocellular carcinoma by regulating autophagy.
Fu N; Du H; Li D; Lu Y; Li W; Wang Y; Kong L; Du J; Zhao S; Ren W; Han F; Wang R; Zhang Y; Nan Y
Life Sci; 2020 Sep; 256():117911. PubMed ID: 32504756
[TBL] [Abstract][Full Text] [Related]
7. Development of biomarkers for screening hepatocellular carcinoma using global data mining and multiple reaction monitoring.
Kim H; Kim K; Yu SJ; Jang ES; Yu J; Cho G; Yoon JH; Kim Y
PLoS One; 2013; 8(5):e63468. PubMed ID: 23717429
[TBL] [Abstract][Full Text] [Related]
8. Insights into significant pathways and gene interaction networks in peripheral blood mononuclear cells for early diagnosis of hepatocellular carcinoma.
Jiang JX; Yu C; Li ZP; Xiao J; Zhang H; Chen MY; Sun CY
J Cancer Res Ther; 2016; 12(2):981-9. PubMed ID: 27461685
[TBL] [Abstract][Full Text] [Related]
9. A blood-based three-gene signature for the non-invasive detection of early human hepatocellular carcinoma.
Shi M; Chen MS; Sekar K; Tan CK; Ooi LL; Hui KM
Eur J Cancer; 2014 Mar; 50(5):928-36. PubMed ID: 24332572
[TBL] [Abstract][Full Text] [Related]
10. Identification of BHLHE40 expression in peripheral blood mononuclear cells as a novel biomarker for diagnosis and prognosis of hepatocellular carcinoma.
Kunadirek P; Ariyachet C; Sriphoosanaphan S; Pinjaroen N; Sirichindakul P; Nookaew I; Chuaypen N; Tangkijvanich P
Sci Rep; 2021 May; 11(1):11201. PubMed ID: 34045534
[TBL] [Abstract][Full Text] [Related]
11. Filamin A expression predicts early recurrence of hepatocellular carcinoma after hepatectomy.
Donadon M; Di Tommaso L; Soldani C; Franceschini B; Terrone A; Mimmo A; Vitali E; Roncalli M; Lania A; Torzilli G
Liver Int; 2018 Feb; 38(2):303-311. PubMed ID: 28727243
[TBL] [Abstract][Full Text] [Related]
12. Clusterin protects hepatocellular carcinoma cells from endoplasmic reticulum stress induced apoptosis through GRP78.
Wang C; Jiang K; Gao D; Kang X; Sun C; Zhang Q; Li Y; Sun L; Zhang S; Guo K; Liu Y
PLoS One; 2013; 8(2):e55981. PubMed ID: 23457489
[TBL] [Abstract][Full Text] [Related]
13. [Down-regulated clusterin expression enhances sensitivity of hepatoma cells to anti-cancer drugs].
Zheng WJ; Sai WL; Yao M; Cai Y; Pan LH; Gu JJ; Wu W; Yao DF
Zhonghua Gan Zang Bing Za Zhi; 2015 Nov; 23(11):844-8. PubMed ID: 26743245
[TBL] [Abstract][Full Text] [Related]
14. Clusterin plays an important role in hepatocellular carcinoma metastasis.
Lau SH; Sham JS; Xie D; Tzang CH; Tang D; Ma N; Hu L; Wang Y; Wen JM; Xiao G; Zhang WM; Lau GK; Yang M; Guan XY
Oncogene; 2006 Feb; 25(8):1242-50. PubMed ID: 16247463
[TBL] [Abstract][Full Text] [Related]
15. Combination of miR-125b and miR-27a enhances sensitivity and specificity of AFP-based diagnosis of hepatocellular carcinoma.
Zuo D; Chen L; Liu X; Wang X; Xi Q; Luo Y; Zhang N; Guo H
Tumour Biol; 2016 May; 37(5):6539-49. PubMed ID: 26637228
[TBL] [Abstract][Full Text] [Related]
16. circ_0067934: A Potential Biomarker and Therapeutic Target for Hepatocellular Carcinoma.
Zhou C; Li R; Mi W
Ann Clin Lab Sci; 2020 Nov; 50(6):734-738. PubMed ID: 33334787
[TBL] [Abstract][Full Text] [Related]
17. Circular RNA expression profiles of peripheral blood mononuclear cells in hepatocellular carcinoma patients by sequence analysis.
Lei B; Zhou J; Xuan X; Tian Z; Zhang M; Gao W; Lin Y; Ni B; Pang H; Fan W
Cancer Med; 2019 Apr; 8(4):1423-1433. PubMed ID: 30714679
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of prothrombin induced by vitamin K absence, macrophage migration inhibitory factor and Golgi protein-73 versus alpha fetoprotein for hepatocellular carcinoma diagnosis and surveillance.
Ismail MM; Morsi HK; Abdulateef NA; Noaman MK; Abou El-Ella GA
Scand J Clin Lab Invest; 2017 May; 77(3):175-183. PubMed ID: 28276727
[TBL] [Abstract][Full Text] [Related]
19. [Characteristic genomics of peripheral blood mononuclear cells of hepatocellular carcinoma patients with liver-kidney yin deficiency syndrome].
Weng L; Du J; He WT; Ling CQ
Zhong Xi Yi Jie He Xue Bao; 2012 Apr; 10(4):406-15. PubMed ID: 22500714
[TBL] [Abstract][Full Text] [Related]
20. Circulating microRNA profiles in plasma: identification of miR-224 as a novel diagnostic biomarker in hepatocellular carcinoma independent of hepatic function.
Okajima W; Komatsu S; Ichikawa D; Miyamae M; Kawaguchi T; Hirajima S; Ohashi T; Imamura T; Kiuchi J; Arita T; Konishi H; Shiozaki A; Moriumura R; Ikoma H; Okamoto K; Taniguchi H; Itoh Y; Otsuji E
Oncotarget; 2016 Aug; 7(33):53820-53836. PubMed ID: 27462777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
